WHY MEASURE NT-PROBNP SERIALLY IN CHRONIC HEART FAILURE? MECHANISTIC ASSOCIATIONS OF NATRIURETIC PEPTIDE SLOPE FOLLOWING INITIATION OF SACUBITRIL/VALSARTAN

被引：0
|
作者：
Mohebi, Reza [1 ]
Liu, Yuxi [1 ]
Myhre, Peder Langeland [1 ]
Felker, Michael [1 ]
Prescott, Margaret [1 ]
Pina, Ileana L. [1 ]
Butler, Javed [1 ]
Ward, Jonathan [1 ]
Solomon, Scott D. [1 ]
Januzzi, James L., Jr. [1 ]
机构：
[1] Harvard Med Univ, Massachusetts Gen Hosp, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 81卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1593-159
引用
收藏
页码：635 / 635
页数：1
相关论文
共 50 条
  • [1] Clinical Implications of NT-proBNP trajectory following Sacubitril/Valsartan initiation
    Takigami, Y.
    Ishii, S.
    Iida, Y.
    Ikeda, Y.
    Nabeta, T.
    Ako, J.
    Nasu, T.
    Kanaoka, K.
    Kagiyama, N.
    Kida, K.
    Fujimoto, W.
    Kikuchi, A.
    Ijichi, T.
    Shibata, T.
    Matsumoto, S.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [2] Heart Failure Phenotypes According to Natriuretic Peptide Trajectory Following Initiation of Sacubitril/Valsartan
    Mohebi, Reza
    Liu, Yuxi
    Myhre, Peder L.
    Felker, G. Michael
    Prescott, Margaret F.
    Pina, Ileana L.
    Butler, Javed
    Ward, Jonathan H.
    Solomon, Scott D.
    Januzzi Jr, James L.
    JACC-HEART FAILURE, 2023, 11 (07) : 855 - 858
  • [3] Deconvolution of BNP and NT-proBNP Immunoreactivities by Mass Spectrometry in Heart Failure and Sacubitril/Valsartan Treatment
    Nougue, Helene
    Michel, Thibault
    Picard, Francois
    Lassus, Johan
    Sadoune, Malha
    Laribi, Said
    Cohen-Solal, Alain
    Logeart, Damien
    Launay, Jean-Marie
    Vodovar, Nicolas
    CLINICAL CHEMISTRY, 2023, 69 (04) : 350 - 362
  • [4] SACUBITRIL / VALSARTAN IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION: COMPARATIVE PROFILE OF NT-PROBNP AND BNP
    Ajello, L.
    Romano, G.
    Agnese, V.
    Bellavia, D.
    Di Gesaro, G.
    Falletta, C.
    La Franca, E.
    Mina, C.
    Storniolo, S.
    Clemenza, F.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0E) : E223 - E224
  • [5] Clinical predictors of NT-proBNP response to early initiation of sacubitril/valsartan after hospitalisation for decompensated heart failure: An analysis of the TRANSITION study
    Pascual-Figal, D.
    Bao, W.
    Senni, M.
    Wachter, R.
    Behlolavek, J.
    Chakrabarti, A.
    Noe, A.
    Schwende, H.
    Butylin, D.
    Prescott, M.
    EUROPEAN HEART JOURNAL, 2019, 40 : 736 - 736
  • [6] NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction TRANSITION Study
    Pascual-Figal, Domingo
    Wachter, Rolf
    Senni, Michele
    Bao, Weibin
    Noe, Adele
    Schwende, Heike
    Butylin, Dmytro
    Prescott, Margaret F.
    JACC-HEART FAILURE, 2020, 8 (10) : 822 - 833
  • [7] Natriuretic peptide variability in a community heart failure population: is there a difference between BNP and NT-proBNP?
    Hanlon, R. O.
    Lange, S.
    Phelan, D.
    Loughlin, C. O.
    Shea, P. O.
    Ledwidge, M.
    Cunningham, S.
    Mc Donald, K.
    EUROPEAN HEART JOURNAL, 2006, 27 : 214 - 214
  • [8] Associations between NT-proBNP and psychosocial factors in patients with chronic systolic heart failure
    Mueller-Tasch, Thomas
    Krug, Katja
    Peters-Klimm, Frank
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2021, 143
  • [9] Racial and ethnic differences in NT-proBNP concentrations and reverse cardiac remodeling in patients with systolic heart failure treated with sacubitril/valsartan
    Ibrahim, N. Nasrien
    Pina, I. L.
    Camacho, A.
    Bapat, D.
    Butler, J.
    Felker, G. M.
    Maisel, A. S.
    Prescott, M. F.
    Abbass, C. A.
    Solomon, S. D.
    Januzzi, J. L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 94 - 94
  • [10] Effect of sacubitril-valsartan on chronic systolic heart failure and its effect on LVEF, 6-MWT, NT proBNP and NT proBNP/BNP levels
    Duan, Yan
    Yu, Meimei
    Xu, Yan
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2023, 22 (06) : 1335 - 1340
12345